TNFSF4 and neoplasm: Intratumoral administration of LNP-formulated N1-methylpseudouridine-modified mRNAs encoding IL-36γ (a pro-inflammatory cytokine acting as alarmin), IL-23 (a regulator of inflammation) and OX40L demonstrated regression of established tumors in three syngeneic tumor models [199].